期刊文献+

肝豆状核变性^(99m)Tc-TRODAT-1的SPECT脑DAT显像研究 被引量:4

The study of ^(99m)Tc-TRODAT-1 SPECT in Wilson's disease patients.
下载PDF
导出
摘要 目的研究肝豆状核变性(WD)患者99mTc-TRODAT-1 SPECT脑DAT显像特点及其与神经系统表现的关系。方法对18例有神经症状WD患者(脑型)、11例无神经症状WD患者(非脑型)和12例正常对照行99m Tc-TRODAT-1 SPECT脑DAT显像,利用计算机感兴趣技术(ROI)进行半定量分析(ST/CB比值作为半定量指标)。据WD神经症状改良评分表对18例脑型WD患者的神经症状进行评分。结果脑型WD患者ST/CB比值与正常对照组比较有显著性差异(P<0.01),非脑型WD患者ST/CB比值与正常对照组比较无显著性差异(P=0.13)。脑型WD患者神经症状改良评分与其ST/CB比值呈高度负相关,r=-0.78(P=0.001)。结论本研究结果提示WD患者DA能黑质纹状体通路突触前膜功能下降,其下降越明显,WD的神经症状就越严重。无神经症状的WD患者脑DAT功能无此改变。 Objective To study the traits of ^99mTc-TRODAT-1 SPECT in Wilson's disease (WD) patients and its relation with clinical manifestations. Methods There were 18 cases of brain group, 11 cases of non-brain group and 12 matched control subjects who underwent ^99mTc-TRODAT-1 SPECT. Specific striatal ^99mTc-TRODAT-1 binding ratios ST/CB ( with the cerebellum as the reference region) were calculated after the application of a region-of-interest (ROI) and assessed as semi-quantified parameters. Prominent neurological symptoms were registered and its severity was scored according to WD amending inquiry. Results The ST/CB of brain group were significantly decreased ( P 〈 0. 01 ) compared with control subjects. But the ST/CB of non-brain group was not different from those of control subjects. The ST/CB of brain group showed negatively correlated with the scores of WD amending inquiry. This correlation was proved to be linear and highly significant ( r = - 0. 78, P = 0. 001 ). Conclusions This study suggests DAT was loss in presynaptic dopaminergic nerve terminals that were significantly correlated with the severity of the neurological symptoms in patients with neurological involvements. This maybe show that the more dominant the loss of DAT is, the more severe the neurological symptoms are. And there was no DAT change in the patients without neurological involvements.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2006年第6期537-539,共3页 Chinese Journal of Nervous and Mental Diseases
关键词 肝豆状核变性(WD) 多巴胺转运体(DAT) ^99mTcTc—TRODAT—1 SPECT Wilson disease(WD) Dopaminergic transporter(DAT) ^99mTc-TRODAT-1 Single photon emission computed tomography (SPECT)
  • 相关文献

参考文献11

  • 1Jeon B,Kim JM,Jeong JM,et al.Dopamine transporter imaging with[^123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.J Neurol Neurosurg Psychiatry,1998,65(2):60.
  • 2Barthel H,Hermann W,Kluge R,et al.Concordant Pre-and Postsynaptic Deficits of Dopaminergic Neurotransmission in Neurological Wilson Disease.American Journal of Neuroradiology,2003,24 (8):234.
  • 3Snow BJ,Bhatt M,Martin WR,et al.The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.J Neurol Neurosurg Psychiatry,1991,54 (1):12.
  • 4Westermark K,Tedroff J,Thoumas KA,et al.Neurological Wilson's disease studies with magnetic resonance imaging and with position emission tomography using dopaminergic markers.Mov Disord,1995,10(12):596.
  • 5Hawkins R,Mazziotta J,Phelps M,et al.Wilson's disease studied with FDG and position emission tomography.Neurology,1985,37 (11):1707.
  • 6W.Hermann,H.Barthel,S.Hease,et al.Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions.J Neurol,2002,249 (2):896.
  • 7Schlaug G,Hefter H,Nebeling B,et al.Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillaminetherapy in Wilson's disease.J Neurol,1994,241 (10):577.
  • 8Oertel WH,Tastsh K,Schwarz J,et al.Decrease of D2 Receptors Indicated by 123I-Iodobenzamide Single-Photon Emission Computed Tomography Relates to Neurological Deficit in Treated Wilson's Disease.Ann Neurol,1992,32 (6):743.
  • 9Oder W,Brucke T,Kollegger H,et al.Dopamine D2 receptor binding is reduced in Wilson's disease:correlation of neurological deficits with striatal[^123I]-iodobenzamide binding.J Neurol Transm,1996,103(8 -9):1093.
  • 10Tatsch K,Schwarz J,Oertel WH,et al.SPECT imaging of dopamine D2 receptors with ^123I-IBZM:initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.Nucl Med Commun,1991,12 (8):699.

同被引文献60

  • 1黄丽,李洵桦,梁秀龄,李爱萍,庄甲军.影响肝豆状核变性患者预后及疗效因素的研究[J].中国神经精神疾病杂志,2006,32(1):11-14. 被引量:19
  • 2戴蓉,刘晓加,邵明,吴卓华,尹文刚.帕金森病患者汉语书写特点[J].中国临床康复,2006,10(38):4-7. 被引量:2
  • 3刘晓加,梁秀龄,陆兵勋,李卫平,林丽珍.汉语失写检查法的制定和标准化[J].中国神经精神疾病杂志,1996,22(6):331-333. 被引量:17
  • 4刘国荣,李月春,李燕,姜华,吕培功.肝豆状核变性患者的神经心理学障碍[J].中华神经科杂志,1996,29(2):126-127. 被引量:1
  • 5Ala A, Walker AP, Ashkan K, et al. Wilson's disease [J]. Lancet, 2007, 369 (9559) : 397 - 408.
  • 6Teichmann M, Dupoux E, Kouider S, et al. The role of the striaturn in processing language rules : evidence from word perception in Huntington's disease [ J ]. J Cogn Neurosci, 2006, 18 ( 9 ) : 1 - 15.
  • 7Tettamanti M, Moro A, Messa C, et al. Basal ganglia and language : phonology modulates dopaminergic release [ J ]. Neuroreport, 2005, 16(4) : 397 -401.
  • 8Ullman MT, Corkin S, Coppola M, et al. A neural dissociation within language : evidence that the mental dictionary is part of declarative memory, and that grammatical rules are processed by the procedural system [J]. J Cogn Neurosci, 1997, 9(2): 266- 276.
  • 9Teichmann M, Gaura V, Demonet J, et al. Language processing within the striatum: evidence from a PET correlation study in Huntington's disease [ J]. Brain, 2008, 131 (Pt 4) : 1046 - 1056.
  • 10刘晓加.书写障碍[M]∥高素容.失语症(第2版).北京:北京大学医学出版社,2006:137-147.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部